Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Incorporated (PRLD) is a healthcare company (biotechnology) based in the United States. The share price is $3.32, down 2.79% on the day, which values the company at $264.55M. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$3.32−2.79% today
Market value
$264.55M
200-week average
$3.242% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Prelude Therapeutics Incorporated in more detail

PRLD trades at -5.7× next year's expected earnings, 12.3× sales. It sits 2% above its 200-week average of $3.24.

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

2 of the superinvestors tracked here hold PRLD, including Peter Kolchinsky (0.3% of the portfolio), Julian and Felix Baker (0.3% of the portfolio).

Superinvestors holding PRLD

2 of the investors tracked here report a position in their latest 13F filing.

Prelude Therapeutics Incorporated (PRLD): questions and answers

What is Prelude Therapeutics Incorporated's market cap?

Prelude Therapeutics Incorporated is valued at $264.55M at a share price of $3.32.

Is PRLD above its 200-week moving average?

Yes. PRLD is 2.3% above its 200-week average of $3.24. Long-term investors watch that line because strong companies rarely trade below it for long.

Does PRLD pay a dividend?

Prelude Therapeutics Incorporated does not currently pay a regular dividend.

Which famous investors own PRLD?

In their latest quarterly filings, Peter Kolchinsky (0.3% of the portfolio), Julian and Felix Baker (0.3% of the portfolio) hold PRLD. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Prelude Therapeutics Incorporated (PRLD) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/PRLD

Underlying data: Yahoo Finance; company filings with the SEC.